News Image

Evaluating NASDAQ:AXON for Growth Investment Opportunities.

By Mill Chart

Last update: Mar 22, 2024

In this article we will dive into AXON ENTERPRISE INC (NASDAQ:AXON) as a possible candidate for growth investing. Investors should always do their own research, but we noticed AXON ENTERPRISE INC showing up in our CANSLIM growth screen, which makes it worth to investigate a bit more.

Some of the canslim metrics of NASDAQ:AXON highlighted

  • In the most recent financial report, AXON ENTERPRISE INC reported a 60.0% increase in quarterly earnings compared to the previous quarter. This notable growth indicates positive momentum in the company's financials, suggesting an upward trend
  • AXON ENTERPRISE INC has experienced 28.58% q2q revenue growth, indicating a significant sales increase.
  • The 3-year EPS growth of AXON ENTERPRISE INC (32.14%) highlights the company's ability to consistently improve its earnings performance and suggests a positive outlook for future profitability.
  • AXON ENTERPRISE INC exhibits a strong Return on Equity (ROE) of 10.8%, indicating the company's ability to generate solid returns on shareholder investments. This metric reflects the company's efficient utilization of equity capital and its profitability.
  • AXON ENTERPRISE INC has achieved an impressive Relative Strength (RS) rating of 87.86, showcasing its ability to outperform the broader market. This strong performance positions AXON ENTERPRISE INC as an attractive stock for potential price appreciation.
  • AXON ENTERPRISE INC exhibits a favorable Debt-to-Equity ratio at 0.42. This highlights the company's ability to limit excessive debt levels and maintain a strong equity base, demonstrating its financial stability and risk management practices.
  • AXON ENTERPRISE INC demonstrates a balanced ownership structure, with institutional shareholders at 75.45%. This indicates a diverse investor base, which can contribute to price stability and potential future growth.

Deciphering the Technical Picture of NASDAQ:AXON

Every day ChartMill assigns a Technical Rating to every stock. The score ranges from 0 to 10 and is determined by evaluating multiple technical indicators and properties.

We assign a technical rating of 10 out of 10 to AXON. Both in the recent history as in the last year, AXON has proven to be a steady performer, scoring decent points in every aspect analyzed.

  • Both the short term and long term trends are positive. This is a very positive sign.
  • Looking at the yearly performance, AXON did better than 87% of all other stocks. On top of that, AXON also shows a nice and consistent pattern of rising prices.
  • AXON is currently trading near its 52 week high, which is a good sign. The S&P500 Index however is also trading near new highs, which makes the performance in line with the market.
  • AXON is currently showing a bull flag pattern! A bull flag pattern occurs when prices pull back slightly after a strong rise up. This may be a nice opportunity for an entry.
  • AXON is part of the Aerospace & Defense industry. There are 65 other stocks in this industry, AXON did better than 67% of them.

Check the latest full technical report of AXON for a complete technical analysis.

A complete fundamental analysis of NASDAQ:AXON

Every day ChartMill assigns a Fundamental Rating to every stock. The score ranges from 0 to 10 and is determined by evaluating multiple fundamental indicators and properties.

We assign a fundamental rating of 6 out of 10 to AXON. AXON was compared to 65 industry peers in the Aerospace & Defense industry. While AXON has a great health rating, its profitability is only average at the moment. AXON shows excellent growth, but is valued quite expensive already. These ratings would make AXON suitable for growth investing!

Check the latest full fundamental report of AXON for a complete fundamental analysis.

Our CANSLIM screen will find you more ideas suited for growth investing.

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

AXON ENTERPRISE INC

NASDAQ:AXON (4/19/2024, 7:00:00 PM)

After market: 294 +0.39 (+0.13%)

293.605

-3.98 (-1.34%)

AXON News

News Image4 days ago - Market News VideoInteresting AXON Put And Call Options For June 2025
News Image5 days ago - Market News VideoAgree To Buy Axon Enterprise At $170, Earn 4.1% Using Options
News Image6 days ago - ChartmillIs AXON ENTERPRISE INC (NASDAQ:AXON) suited for growth investing?

Why the CANSLIM investor may take a look at AXON ENTERPRISE INC (NASDAQ:AXON).

News Image10 days ago - Market News VideoS&P 500 Analyst Moves: AXON
News Image11 days ago - ChartmillWhich S&P500 stocks are moving on Wednesday?

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday.

News Image11 days ago - ChartmillWondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

What's going on in today's session: S&P500 movers

News Image14 days ago - The Motley FoolForget Nvidia: These Are Likely the Next Once-in-a-Generation Tech Stocks to Buy

Although Nvidia should continue to prosper, other tech companies are also poised for outsize returns.

News Image15 days ago - Investor's Business DailyMicrosoft And AI Play Lead Five Stocks Near Buy Points

Microsoft and another AI play lead this weekend's watch list.

News Image20 days ago - InvestorPlace3 Overvalued S&P 500 Stocks for Your ‘Do NOT Buy’ List

The S&P 500’s current P/E ratio is 30% higher than a year ago, making it easier to find overvalued S&P 500 stocks to buy.

News Image22 days ago - Investor's Business DailyUber Leads Five Stocks Near Buy Points

Five resilient stocks are setting up or flirting with entries.

News Imagea month ago - InvestorPlace3 Promising Small-Cap Stocks Packing a Powerful Punch

Here're three under-the-radar small-cap stocks with robust growth potential that could deliver outsized returns for risk-tolerant investors.

News Imagea month ago - The Motley FoolThe AI Race Gets Litigious

We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade.

AXON Links
Follow us for more